Kai Ding, Ph.D.

Ding_Kai 2017

Associate Professor

Phone: (405) 271-2229 x48737
Office: The University of Oklahoma Health Sciences Center
801 Northeast 13th Street, Room 329
Post Office Box 26901
Oklahoma City, Oklahoma 73126-0901
Email: Kai-Ding@ouhsc.edu
Research Profile: http://profiles.ouhsc.edu/display/74336

Education and Training

  • Ph.D., Biostatistics, 2010, University of North Carolina at Chapel Hill
  • M.S., Statistics, 2005, University of Kentucky
  • B.S., Statistics, 2002, Fudan University

Teaching:

  • BSE 6643 Survival Data Analysis
  • BSE 5733 Principles of Mathematical Statistics I
  • BSE 5743 Principles of Mathematical Statistics II

Complete List of Publications:

http://profiles.ouhsc.edu/display/74336

Selected Publications:

  • Dockery, L.E., Tew, W.P., Ding, K., Moore, K.N. (2017). Tolerance and toxicity of the PARP inhibitor olaparib in older women with epithelial ovarian cancer. Gynecologic Oncology. 147: 509-513.
  • Chakraborty, P.K., Mustafi, S.B., Xiong, X., Dwivedi, S.D., Nesin, V., Saha, S., Zhang, M., Dhanasekaran, D., Jayaraman, M., Mannel, R., Moore, K., McMeekin, S., Yang, D., Zuna, R., Ding, K., Tsiokas, L., Bhattacharya, R., Mukherjee, P. (2017). MICU1 drives glycolysis and chemoresistance in ovarian cancer. Nature Communications. 8: 14634.
  • Knafl, G. J., Ding, K. (2016). Adaptive regression for modeling nonlinear relationships. New York: Springer.
  • Allan, E.J., Khaimi, M.A., Jones, J.M., Ding, K., Skuta, G.L. (2015). Long-term efficacy of the Baerveldt 250mm2 compared with the Baerveldt 350mm2 implant. Ophthalmology. 122: 486-493.
  • Ding, K., Kosorok, M., Zeng, D. (2013). On the local and stratified likelihood approaches in single-index hazards model. Communication in Mathematics and Statistics. 1: 115-132.

     

Research Grants:

http://profiles.ouhsc.edu/display/74336

Research Interests:

  • Semiparametric modeling, Survival analysis, High dimensional data
  • Gastrointestinal and gynecological cancers, Ophthalmology

Current Research Projects:

  • NIH/R01 1R01CA214017, “The role of Dclk1 in the initiation of colorectal cancer", (PI: Houchen). Role: Co-Investigator
  • NIH/R01 7R01CA182869, “The role of DCLK1 in the initiation of pancreatic ductal adenocarcinoma", (PI: Houchen). Role: Co-Investigator
  • NIH/R01 7R01CA203108, “Prognostic biomarkers for ZIP4-mediated cachexia in pancreatic cancer", (PI: Li). Role: Co-Investigator
  • NIH/R01 7R01CA186338, “ZIP4 is a novel molecular target in human pancreatic cancer", (PI: Li). Role: Co-Investigator
  • NIH/R01 1R01CA213278, “Reprogramming tumor microenvironment by nanoparticle", (PI: Mukherjee). Role: Co-Investigator
  • NIH/P20 1P20CA202921, “Vaping among smokers: a Cherokee Nation cohort study", (PI: Rhoades). Role: Co-Investigator